Nanoparticle Delivery of Delamanid for Cost-effective Treatment of Tuberculosis, Satya K Nayagam, UG '22 (2310833)Tuberculosis remains a major health issue in the world today with over 10 million cases a year. Delamanid (Deltyba) is a new drug for the treatment of multidrug-resistant TB that was approved in…
From Research Princeton Research Day
4
4 likes
| 148
148 plays
|
© 2022 The Trustees of Princeton University
Broadcast Center | 1E12 Green Hall | Princeton, NJ 08544 | 609.258.7872 | [email protected]